HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EC's Non-Automatic Ban Policy For CMRs In Cosmetics 'Plainly Illegal' – NGOs

This article was originally published in The Rose Sheet

Executive Summary

According to the consumer umbrella organization BEUC, the European Commission changed its tune last year on whether carcinogenic, mutagenic or reprotoxic substances are automatically prohibited from use in cosmetics, taking a direction that compromises public safety and invites legal challenges. The EC maintains it has provided procedural and legal clarity while upholding the Cosmetics Regulation's general CMR ban.

You may also be interested in...



Future Use Of Titanium Dioxide In Spray And Powder Cosmetics Hinges On SCCS Review

As of 5 February, the Scientific Committee on Consumer Safety is evaluating use of titanium dioxide – now officially classified as a Category 2 carcinogen in the EU – in cosmetic products that can expose consumers by way of inhalation. Without a favorable SCCS opinion, the ingredient’s use in those contexts will be banned under Article 15 of the Cosmetics Regulation.

Cosmetics Europe Strategizing To Defend Ingredients Flagged As Endocrine Disruptors, CMRs

Clarification of requirements and a “demanding” timeline for industry’s defense of cosmetic ingredients identified as potentially carcinogenic, mutagenic or reprotoxic, and the Commission’s forthcoming list of potential endocrine disruptors in cosmetic products, are among challenges facing Cosmetics Europe in 2019 and beyond.

EU Watch: Next Steps Re Controversial CMR Ban Approach, Fragrance Allergens Labeling

EU sources update Rose Sheet on contentious initiatives to cement the Commission’s pathway for banning carcinogenic, mutagenic or reprotoxic substances in cosmetics and to promote fragrance allergen awareness and risk management.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121415

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel